Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 72.635 USD 2.88%
Market Cap: 12.5B USD
Have any thoughts about
Insmed Inc?
Write Note

Insmed Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Insmed Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Insmed Inc
NASDAQ:INSM
Cash from Operating Activities
-$574.1m
CAGR 3-Years
-20%
CAGR 5-Years
-15%
CAGR 10-Years
-25%
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$16.5B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$10B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$7.3B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
-$944m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.2B
CAGR 3-Years
-11%
CAGR 5-Years
12%
CAGR 10-Years
18%

See Also

What is Insmed Inc's Cash from Operating Activities?
Cash from Operating Activities
-574.1m USD

Based on the financial report for Jun 30, 2024, Insmed Inc's Cash from Operating Activities amounts to -574.1m USD.

What is Insmed Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-25%

Over the last year, the Cash from Operating Activities growth was -24%. The average annual Cash from Operating Activities growth rates for Insmed Inc have been -20% over the past three years , -15% over the past five years , and -25% over the past ten years .

Back to Top